AI can be applied to patient data in real time, allowing medical reviewer teams to actively monitor patient safety, with the AI alerting medical review teams to identify potential adverse events (AEs), data anomalies, critical issues for patients on treatment, and more.
Related Posts
Empowering Sponsors to Drive Trial Success
Attend this new, interactive webinar and join experts who reveal how sponsors can leverage technology to drive study efficiency. Learn…
Digital biomarkers show early clinical validity and provide greater confidence in Movement Disorder clinical trials
Digital biomarkers, smartphones, and wearables are transforming clinical trials by revolutionizing remote data collection and providing insights into treatment efficacy.…
Advancing for Patients
Mike Hennessy Jr, president and CEO, MJH Life Sciences® A popular topic of discussion in clinical research in recent years…